Skip to main content
. 2020 Oct 20;12(10):997. doi: 10.3390/pharmaceutics12100997

Table 2.

DFE exposure scenarios used in the PBPK simulations.

Subject/Scenario Inhaled Concentration Total Abuse Duration Inhalation Duration Inhalation Cycle
X 1,000,000 ppm 6 h 1.5–8 s 3–5 min
Y 1,000,000 ppm 2 h 5–15 s 2–5 min